Urine Drug Testing Adulteration Assay
Coccidioides Antigen
Gabapentin, Urine
Phenosense Entry HIV Drug Resistance Assay
MYOZ2 (Calsarcin-1) Gene Mutation Analysis
Trimethoprim, Serum
Spinocerebellar Ataxia Type 3 (SCA3) (Machado-Joseph Disease) Gene Mutation Analysis
Ovarian germ cell neoplasm
Mumps Virus Antibody, IgM
Cytochrome P450 2A6 (CYP2A6) Genotyping
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
References
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now